Dr Farshad Guirakhoo, CSO of ES2B presents as an invited speaker the principle of VLP of AV in context of HER2-VLP vaccine candite. He also shows data for preclinical POC studies for efficacy of the vaccine as prophylactic and therapeutic in Tg mice.

More about the event at: https://www.terrapinn.com/conference/world-vaccine-congress-washington/index.stm